Earnings History Data for CRISPR Therapeutics AG (CRSP) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

CRISPR Therapeutics AG

CRISPR Therapeutics AG is a gene-editing company. It focused on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR Therapeutics AG is headquartered in Basel, Switzerland.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
21-02-2024	PM		CRSP	CRISPR Therapeutics AG	6,710	1.10	-0.40	-1.41	CRISPR Therapeutics GAAP EPS of $1.10 beats by $1.33 [2/21/2024 7:44 AM]	82.19	3.46 (4.39%)	82.47	3.74 (4.75%)	37.55 - 90.18	2,792,751	2,820,000	153,634
CRISPR Therapeutics GAAP EPS of $1.10 beats by $1.33 [2/21/2024 7:44 AM] CRISPR beats in Q4 as Casgevy approval boosts topline [2/21/2024 8:48 AM]
06-11-2023	AH		CRSP	CRISPR Therapeutics	3,667	-1.41	-1.98	0.00	CRISPR Therapeutics GAAP EPS of -$1.41 beats by $0.57 [11/6/2023 5:23 PM]	58.60	7.02 (13.61%)	52.25	0.67 (1.30%)	37.55 - 72.00	3,496,321	2,420,000	40,883
CRISPR Therapeutics GAAP EPS of -$1.41 beats by $0.57 [11/6/2023 5:23 PM] Crispr Therapeutics Q3 results see muted response despite earnings beat [11/7/2023 7:20 AM]
07-08-2023	AH		CRSP	CRISPR Therapeutics	4,053	-0.98	-2.18	0.00	CRISPR Therapeutics GAAP EPS of -$0.98 beats by $1.12, revenue of $70M [8/7/2023 4:55 PM]	53.09	4.75 (9.83%)	49.05	0.71 (1.47%)	38.94 - 84.10	2,184,887	1,070,000	11,963
CRISPR Therapeutics GAAP EPS of -$0.98 beats by $1.12, revenue of $70M [8/7/2023 4:55 PM] Why did CRISPR Therapeutics stock soar today? Q2 results [8/8/2023 3:46 PM]
01-11-2022	AH	After the close (Nov 1)	CRSP	CRISPR Therapeutics	4,235	-2.24	-2.30	0.00	CRISPR Therapeutics GAAP EPS of -$2.24 beats by $0.02, revenue of $0.09M misses by $1.77M [11/1/2022 5:09 PM]	54.69	2.67 (5.13%)	54.44	2.42 (4.65%)	42.51 - 98.58	1,318,671	1,010,000	797
CRISPR Therapeutics GAAP EPS of -$2.24 beats by $0.02, revenue of $0.09M misses by $1.77M [11/1/2022 5:09 PM] CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results [Nov-01-22 04:01PM] CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates [Nov-01-22 05:15PM] CRISPR Therapeutics (CRSP) Q3 Earnings Top, Sales Lag Estimates [Nov-02-22 12:51PM]
08-08-2022	PM	Before the open (Aug 8)	CRSP	CRISPR Therapeutics	6,112	-2.40	-2.23	0.00	CRISPR Therapeutics GAAP EPS of -$2.40 misses by $0.19, revenue of $0.16M misses by $2.04M [8/8/2022 8:27 AM]	81.36	-0.04 (-0.04%)	80.07	-1.33 (-1.63%)	42.51 - 142.64	1,399,691	1,200,000	7,791
CRISPR Therapeutics GAAP EPS of -$2.40 misses by $0.19, revenue of $0.16M misses by $2.04M [8/8/2022 8:27 AM] CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results [Aug-08-22 08:00AM]
09-05-2022	AH	4:00 PM ET (May 9)	CRSP	CRISPR Therapeutics	3,974	-2.32	-1.91	0.00	CRISPR Therapeutics GAAP EPS of -$2.32 misses by $0.38, revenue of $0.94M misses by $1.51M [5/9/2022 5:22 PM]	47.32	4.09 (9.46%)	44.63	1.40 (3.24%)	43.05 - 169.76	2,172,209	1,380,000	6,963
CRISPR Therapeutics GAAP EPS of -$2.32 misses by $0.38, revenue of $0.94M misses by $1.51M [5/9/2022 5:22 PM] CRISPR stock draws flurry of price target cuts following Q1 result [5/10/2022 9:43 AM] CRISPR Therapeutics Provides Business Update and Reports First Quarter 2022 Financial Results [May-09-22 04:01PM] How Many CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Do Institutions Own? [May-09-22 06:56AM] Vertex (VRTX) Q1 Earnings Lag, Sales Top, Expense View Tweaked [May-06-22 10:37AM] CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Lags Revenue Estimates [May-09-22 05:15PM] CRISPR Therapeutics (CRSP) Q1 Earnings & Sales Miss Estimates [May-10-22 10:30AM]
29-07-2021	AH	4:00 PM ET (Jul 29)	CRSP	Crispr Therapeutics Ag	8,898	9.44	4.19	0.00	CRISPR Therapeutics EPS beats by $5.59, beats on revenue [7/29/2021 4:59 PM]	120.90	1.90 (1.60%)	123.30	4.30 (3.61%)	76.71 - 220.20	1,313,671	1,090,000	23,997
CRISPR Therapeutics EPS beats by $5.59, beats on revenue [7/29/2021 4:59 PM] CRISPR up ~5% after hours after massive Q2 2021 earnings beat [7/29/2021 6:23 PM] CRISPR's Q2 earnings beat thanks to $900M upfront payment from Vertex [7/30/2021 11:05 AM] CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results [Jul-29-21 04:30PM] CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know [Jul-29-21 05:50PM] CRISPR Therapeutics AG (CRSP) Tops Q2 Earnings and Revenue Estimates [Jul-29-21 06:25PM] CRISPR Therapeutics (CRSP) Q2 Earnings Beat, Revenues Up Y/Y [Jul-30-21 10:31AM]
27-04-2021	AH	4:00 PM ET (Apr 27)	CRSP	CRISPR Therapeutics AG	9,510	-1.51	-1.45	-1.15	CRISPR Therapeutics EPS misses by $0.04, misses on revenue [4/27/2021 4:45 PM]	135.42	2.38 (1.79%)	132.00	-1.04 (-0.78%)	46.84 - 220.20	1,183,396	1,720,000	11,179
CRISPR Therapeutics EPS misses by $0.04, misses on revenue [4/27/2021 4:45 PM] Crispr Therapeutics falls as Q1 financials miss the estimates and net loss widens [4/27/2021 10:19 PM] Skyworks Lifts Nasdaq Ahead of Earnings; CRISPR Keeps Moving Forward [Apr-26-21 02:47PM] Vertex and CRISPR Therapeutics Announce Priority Medicines (PRIME) Designation Granted by the European Medicines Agency to CTX001 for Transfusion-Dependent Beta Thalassemia [Apr-26-21 08:30AM] Crispr Therapeutics Gets Relative Strength Rating Upgrade [Apr-27-21 01:53PM] CRISPR Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results [Apr-27-21 04:01PM] CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Misses Revenue Estimates [Apr-27-21 05:15PM] CRISPR Therapeutics (CRSP) Q1 Earnings Miss, Revenues Rise Y/Y [Apr-28-21 09:56AM] Biotech Stock Roundup: BIIB, AMGN's Q1 Earnings Updates & Other Pipeline News [Apr-28-21 12:18PM] CRISPR Therapeutics Announces Trials in Progress Poster Presentation at the 2021 American Society of Clinical Oncology Annual Meeting [Apr-28-21 04:01PM]
16-02-2021	AH	After the close (Feb 16)	CRSP	Crispr Therapeutics Ag	11,468	-1.50	-1.23	0.00	CRISPR Therapeutics EPS misses by $0.23, misses on revenue [2/16/2021 4:18 PM]	149.73	-5.59 (-3.60%)	150.00	-5.32 (-3.43%)	32.30 - 220.20	3,174,236	2,483,346	45,052
CRISPR Therapeutics shares fall on fourth-quarter topline miss [2/17/2021 8:52 AM] Dow Jones Futures: Apple, Tesla Test Support As JPMorgan, Caterpillar Break Out; 7 Key Earnings [Feb-17-21 08:18AM]
16-02-2021	AH	After the close (Feb 16)	CRSP	CRISPR Therapeutics AG	12,100	-1.50	-1.23	0.51	CRISPR Therapeutics EPS misses by $0.23, misses on revenue [2/16/2021 4:18 PM]	149.73	-5.59 (-3.60%)	150.00	-5.32 (-3.43%)	32.30 - 220.20	3,174,236	2,483,346	45,052
CRISPR Therapeutics shares fall on fourth-quarter topline miss [2/17/2021 8:52 AM] Dow Jones Futures: Apple, Tesla Test Support As JPMorgan, Caterpillar Break Out; 7 Key Earnings [Feb-17-21 08:18AM]